ST-segment elevation myocardial infarction
Conditions
Interventions
Observation group : Not available
Sponsors
First Affiliated Hospital of University of Science and Technology of China
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.People over the age of 18 2.Patients diagnosed with ST-segment elevation myocardial infarction (STEMI) 3.Patients with STEMI performed percutaneous coronary intervention (PCI) within 12h of symptom onset 4.Patients who are willing to participate in this study and sign written informed consent
Exclusion criteria
Exclusion criteria: 1.Presence of malignancy 2.Severe liver and/or renal insufficiency (AST or ALT?>?3 times the upper limit of normal, estimated GFR <60 ml/min/1.73) 3.Significant hematologic disorders 4.Patients who have taken hormones or immunosuppressive agents, or have an immunological deficiency disease 5.Presence of connective tissue diseases 6.Patients with heart transplantation or pacemaker implantation 7.Pregnant or lactating women 8.Patients with a clear history of infection within 1 month before the study 9.Participated in other drug or medical device clinical trials within 1 month before enrollment 10.Inability to complete expected follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose profiles assessed by continuous glucose monitoring system;Major Adverse Cardiovascular and Cerebrovascular Events (MACCE); | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in cardiac function;Vascular recanalization outcome;Operation duration;Incidence of intraoperative/postoperative surgical complications;Serum multipoint endocrine hormone levels in stress state; | — |
Countries
China
Contacts
Public ContactHao Hu
First Affiliated Hospital of University of Science and Technology of China
Outcome results
None listed